Interestingly, Merlin-positive grade II meningioma cells responded to MLN3651 treatment after 144 h (IC50 < 3 μM), however, Merlin-deficient grade II meningioma cells remained more sensitive (IC50 < 1 μM) (Figure S5B). The gene discussed is NF2; the disease is meningioma.